Screening for ALK abnormalities in central nervous system metastases of non‐small‐cell lung cancer

Anaplastic lymphoma kinase (ALK) gene rearrangement was reported in 3%–7% of primary non‐small‐cell lung cancer (NSCLC) and its presence is commonly associated with adenocarcinoma (AD) type and non‐smoking history. ALK tyrosine kinase inhibitors (TKIs) such as crizotinib, alectinib and ceritinib sho...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Brain Pathol
Hlavní autoři: Nicoś, Marcin, Jarosz, Bożena, Krawczyk, Paweł, Wojas‐Krawczyk, Kamila, Kucharczyk, Tomasz, Sawicki, Marek, Pankowski, Juliusz, Trojanowski, Tomasz, Milanowski, Janusz
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2017
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8028499/
https://ncbi.nlm.nih.gov/pubmed/27879019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bpa.12466
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky